Mithra Signs Exclusive License and Supply Agreement for Commercialization of Tibelia in Taiwan

Liège, Belgium – 21 September 2018, 07:30 CEST – Mithra Pharmaceuticals (Euronext Brussels: MITRA), a company specialized in Women’s Health, today announced that it has entered into an exclusive license and supply agreement with Pei Li Pharmaceutical Industrial Co, Ltd (“Pei Li Pharm”) to commercialize Tibelia® in Taiwan.

https://investors.mithra.com/wp-content/uploads/2018/09/2018-09-21-Tibol...

 

To read more Press Release articles, click here.